Endothelial activation in lacunar stroke subtypes

Stroke

Volumn 41, Issue 8, 2010, Pages 1617-1622

  Knottnerus, Iris L H ^a,b   Govers Riemslag, Jose W P ^a   Hamulyak, Karly ^a   Rouhl, Rob P W ^a   Staals, Julie ^a   Spronk, Henri M H ^a   Van Oerle, Rene ^a   Van Raak, Elisabeth P M ^a   Lodder, Jan ^a,b   Ten Cate, Hugo ^a,b   Van Oostenbrugge, Robert J ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

endothelial dysfunction; endothelium; lacunar stroke

Indexed keywords

BLOOD CLOTTING FACTOR 8; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOMODULIN; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ARTICLE; BRAIN DAMAGE; ENDOTHELIUM; FEMALE; HUMAN; LACUNAR STROKE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK FACTOR; STROKE; WHITE MATTER LESION;

AGED; BRAIN; BRAIN INFARCTION; ENDOTHELIUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACTOR VIII; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PATIENT SELECTION; PLASMINOGEN ACTIVATOR INHIBITOR 1; REGRESSION ANALYSIS; RISK FACTORS; SMOKING; STATISTICS, NONPARAMETRIC; THROMBOMODULIN; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

EID: 77955172448     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.576223     Document Type: Article

References (35)

1. Bamford J, Sandercock P, Jones L, Warlow C. The natural history of lacunar infarction: The oxfordshire community stroke project. Stroke. 1987;18:545-551.
2. Donnan GA, BN, Bammer R, Bogousslavsky J. Classification of subcortical infarcts. In: Donnan GA, Norrving B, Bamford J, Bogousslavsky J, eds. Subcortical stroke. New York: Oxford University Press; 2002:27-34.
3. Fisher CM. The arterial lesions underlying lacunes. Acta Neuropathol (Berl). 1968;12:1-15.
4. Boiten J, Lodder J, Kessels F. Two clinically distinct lacunar infarct entities? A hypothesis. Stroke. 1993;24:652-656.
5. de Jong G, Kessels F, Lodder J. Two types of lacunar infarcts: Further arguments from a study on prognosis. Stroke. 2002;33:2072-2076.
6. van Swieten JC, van den Hout JH, van Ketel BA, Hijdra A, Wokke JH, van Gijn J. Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. A morphometric correlation with arteriolosclerosis and dilated perivascular spaces. Brain. 1991;114(Pt 2):761-774.
7. Lammie A. The role of oedema in lacune formation. Cerebrovasc Dis. 1998;8:246.
8. Wardlaw JM. What causes lacunar stroke? J Neurol Neurosurg Psychiatry. 2005;76:617-619.
9. Wardlaw JM, Sandercock PA, Dennis MS, Starr J. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke. 2003;34:806-812.
10. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: Testing and clinical relevance. Circulation. 2007;115: 1285-1295.
11. Vischer UM. Von willebrand factor, endothelial dysfunction, and cardiovascular disease. J Thromb Haemost. 2006;4:1186-1193.
12. Mackman N, Tilley RE, Key NS. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol. 2007;27:1687-1693.
13. Spronk HM, Govers-Riemslag JW, ten Cate H. The blood coagulation system as a molecular machine. Bioessays. 2003;25:1220-1228.
14. Collen D, Lijnen HR. Tissue-type plasminogen activator: A historical perspective and personal account. J Thromb Haemost. 2004;2:541-546.
15. Lijnen HR. Pleiotropic functions of plasminogen activator inhibitor-1. J Thromb Haemost. 2005;3:35-45.
16. Hassan A, Hunt BJ, O'Sullivan M, Parmar K, Bamford JM, Briley D, Brown MM, Thomas DJ, Markus HS. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain. 2003;126: 424-432.
17. Staals J, van Oostenbrugge RJ, Knottnerus IL, Rouhl RP, Henskens LH, Lodder J. Brain microbleeds relate to higher ambulatory blood pressure levels in first-ever lacunar stroke patients. Stroke. 2009;40:3264-3268.
18. Rouhl RP, van Oostenbrugge RJ, Knottnerus IL, Staals JE, Lodder J. Virchow-robin spaces relate to cerebral small vessel disease severity. J Neurol. 2008;255:692-696.
19. Ma KC, Olsson Y. Structural and vascular permeability abnormalities associated with lacunes of the human brain. Acta Neurol Scand. 1993; 88:100-107.
20. Wardlaw JM, Dennis MS, Warlow CP, Sandercock PA. Imaging appearance of the symptomatic perforating artery in patients with lacunar infarction: Occlusion or other vascular pathology? Ann Neurol. 2001;50:208-215.
21. Wardlaw JM, Doubal F, Armitage P, Chappell F, Carpenter T, Munoz Maniega S, Farrall A, Sudlow C, Dennis M, Dhillon B. Lacunar stroke is associated with diffuse blood-brain barrier dysfunction. Ann Neurol. 2009;65:194-202.
22. Tohgi H, Utsugisawa K, Yoshimura M, Nagane Y, Ukitsu M. Local variation in expression of pro-and antithrombotic factors in vascular endothelium of human autopsy brain. Acta Neuropathol (Berl). 1999;98: 111-118.
23. Myohanen H, Vaheri A. Regulation and interactions in the activation of cell-associated plasminogen. Cell Mol Life Sci. 2004;61:2840-2858.
24. Soeda S, Koyanagi S, Kuramoto Y, Kimura M, Oda M, Kozako T, Hayashida S, Shimeno H. Anti-apoptotic roles of plasminogen activator inhibitor-1 as a neurotrophic factor in the central nervous system. Thromb Haemost. 2008;100:1014-1020.
25. Benchenane K, Berezowski V, Ali C, Fernandez-Monreal M, Lopez-Atalaya JP, Brillault J, Chuquet J, Nouvelot A, MacKenzie ET, Bu G, Cecchelli R, Touzani O, Vivien D. Tissue-type plasminogen activator crosses the intact blood-brain barrier by low-density lipoprotein receptor-related protein-mediated transcytosis. Circulation. 2005;111:2241-2249.
26. Kozuka K, Kohriyama T, Nomura E, Ikeda J, Kajikawa H, Nakamura S. Endothelial markers and adhesion molecules in acute ischemic stroke-sequential change and differences in stroke subtype. Atherosclerosis. 2002; 161:161-168.
27. Nomura E, Kohriyama T, Kozuka K, Kajikawa H, Nakamura S. Sequential changes in von willebrand factor and soluble thrombomodulin in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2001;10:257-264.
28. Casani L, Sanchez-Gomez S, Vilahur G, Badimon L. Pravastatin reduces thrombogenicity by mechanisms beyond plasma cholesterol lowering. Thromb Haemost. 2005;94:1035-1041.
29. Ishii H, Salem HH, Bell CE, Laposata EA, Majerus PW. Thrombo-modulin, an endothelial anticoagulant protein, is absent from the human brain. Blood. 1986;67:362-365.
30. Wong VL, Hofman FM, Ishii H, Fisher M. Regional distribution of thrombomodulin in human brain. Brain Res. 1991;556:1-5.
31. Tran ND, Wong VL, Schreiber SS, Bready JV, Fisher M. Regulation of brain capillary endothelial thrombomodulin mRNA expression. Stroke. 1996;27:2304-2310.
32. Jackson C, Sudlow C. Are lacunar strokes really different? A systematic review of differences in risk factor profiles between lacunar and non-lacunar infarcts. Stroke. 2005;36:891-901.
33. Chen PL, Wang PY, Sheu WH, Chen YT, Ho YP, Hu HH, Hsu HY. Changes of brachial flow-mediated vasodilation in different ischemic stroke subtypes. Neurology. 2006;67:1056-1058.
34. Kwa VI, van der Sande JJ, Stam J, Tijmes N, Vrooland JL. Retinal arterial changes correlate with cerebral small-vessel disease. Neurology. 2002; 59:1536-1540.
35. Lindley RI, Wang JJ, Wong MC, Mitchell P, Liew G, Hand P, Wardlaw J, De Silva DA, Baker M, Rochtchina E, Chen C, Hankey GJ, Chang HM, Fung VS, Gomes L, Wong TY. Retinal microvasculature in acute lacunar stroke: A cross-sectional study. Lancet Neurol. 2009;8:628-634.